QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) All Versions of this Article: mol.106.033621v1 71/5/1209    most recent Submit a response Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Niforatos, W. Articles by Chen, J. Search for Related Content PubMed PubMed Citation Articles by Niforatos, W. Articles by Chen, J.

Accelerated Communication

Activation of TRPA1 Channels by the Fatty Acid Amide Hydrolase Inhibitor 3'-Carbamoylbiphenyl-3-yl cyclohexylcarbamate (URB597)

Neuroscience Research (W.N., X.-F.Z., T.N., V.E.S., C.R.F., R.B.M., J.C.), and Protein Biochemistry, Advanced Technology (M.R.L., K.A.W., T.F.H.), Global Pharmaceutical Research and Development, Abbott Laboratories, Abbott Park, Illinois

As a member of the transient receptor potential (TRP) ion channel superfamily, the ligand-gated ion channel TRPA1 has been implicated in nociceptive function and pain states. The endogenous ligands that activate TRPA1 remain unknown. However, various agonists have been identified, including environmental irritants (e.g., acrolein) and ingredients of pungent natural products [e.g., allyl isothiocyanate (ITC), cinnamaldehyde, allicin, and gingerol]. In general, these agents are either highly reactive, nonselective, or not potent or efficacious, significantly limiting their utilities in the study of TRPA1 channel properties and biological functions. In a search for novel TRPA1 agonists, we identified 3'-carbamoylbiphenyl-3-yl cyclohexylcarbamate (URB597), a potent and systemically active inhibitor of fatty acid amide hydrolase (FAAH). This enzyme is responsible for anandamide degradation and therefore has been pursued as an antinociceptive and antiepileptic drug target. Using Ca²⁺ influx assays and patch-clamp techniques, we demonstrated that URB597 could activate heterologously expressed human and rat TRPA1 channels, whereas two other FAAH inhibitors (i.e., URB532 and Compound 7) had no effect. When applied to inside-out membrane patches expressing rat TRPA1, URB597 elicited single-channel activities with a unitary conductance of 40 pS. Furthermore, URB597 activated TRPA1 channels endogenously expressed in a population of rat dorsal root ganglion neurons that also responded to ITC. In contrast to its effect on TRPA1, URB597 inhibited TRPM8 and had no effects on TRPV1 or TRPV4. Thus, we conclude that URB597 is a novel agonist of TRPA1 and probably activates the channel through a direct gating mechanism.

Address correspondence to: Dr. Jun Chen, Neuroscience Research, Global Pharmaceutical Research and Development, Abbott Laboratories, Dept. R4PM, Bldg AP9A, 100 Abbott Park Road, Abbott Park, IL 60064-6125. E-mail: jun.x.chen{at}abbott.com

This article has been cited by other articles:

				S. Bang and S. W. Hwang Polymodal Ligand Sensitivity of TRPA1 and Its Modes of Interactions J. Gen. Physiol., March 1, 2009; 133(3): 257 - 262. [Full Text] [PDF]

				J. Chen, X.-F. Zhang, M. E. Kort, J. R. Huth, C. Sun, L. J. Miesbauer, S. C. Cassar, T. Neelands, V. E. Scott, R. B. Moreland, et al. Molecular Determinants of Species-Specific Activation or Blockade of TRPA1 Channels J. Neurosci., May 7, 2008; 28(19): 5063 - 5071. [Abstract] [Full Text] [PDF]

				M. Maher, H. Ao, T. Banke, N. Nasser, N.-T. Wu, J. G. Breitenbucher, S. R. Chaplan, and A. D. Wickenden Activation of TRPA1 by Farnesyl Thiosalicylic Acid Mol. Pharmacol., April 1, 2008; 73(4): 1225 - 1234. [Abstract] [Full Text] [PDF]